Correlation Between HCW Biologics and Apogee Therapeutics,

Can any of the company-specific risk be diversified away by investing in both HCW Biologics and Apogee Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HCW Biologics and Apogee Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between HCW Biologics and Apogee Therapeutics, Common, you can compare the effects of market volatilities on HCW Biologics and Apogee Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HCW Biologics with a short position of Apogee Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of HCW Biologics and Apogee Therapeutics,.

Diversification Opportunities for HCW Biologics and Apogee Therapeutics,

0.21

Correlation Coefficient

HCW Biologics  Apogee Therapeutics,

Modest diversification

The 3 months correlation between HCW and Apogee is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding HCW Biologics and Apogee Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apogee Therapeutics, and HCW Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HCW Biologics are associated (or correlated) with Apogee Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apogee Therapeutics, has no effect on the direction of HCW Biologics i.e., HCW Biologics and Apogee Therapeutics, go up and down completely randomly.

Pair Corralation between HCW Biologics and Apogee Therapeutics,

Given the investment horizon of 90 days HCW Biologics is expected to generate 4.04 times more return on investment than Apogee Therapeutics,. However, HCW Biologics is 4.04 times more volatile than Apogee Therapeutics, Common. It trades about 0.02 of its potential returns per unit of risk. Apogee Therapeutics, Common is currently generating about -0.03 per unit of risk. If you would invest  43.00  in HCW Biologics on December 28, 2024 and sell it today you would lose (13.00) from holding HCW Biologics or give up 30.23% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

HCW Biologics  vs.  Apogee Therapeutics, Common

HCW Biologics

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in HCW Biologics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating basic indicators, HCW Biologics sustained solid returns over the last few months and may actually be approaching a breakup point.

Apogee Therapeutics,

Risk-Adjusted Performance

Very Weak

Over the last 90 days Apogee Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest conflicting performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Pair Trading with HCW Biologics and Apogee Therapeutics,

The main advantage of trading using opposite HCW Biologics and Apogee Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HCW Biologics position performs unexpectedly, Apogee Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apogee Therapeutics, will offset losses from the drop in Apogee Therapeutics,'s long position.

The idea behind HCW Biologics and Apogee Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.